January 27, 2011 The Food and Drug Administration is not willing to expand the approval of an existing drug for enlarged prostates as a means to reduce the risk of prostate cancer. A panel of expert previously recommended against the expansion.
January 24, 2011 GlaxoSmithKline's U.S. President Deirdre Connelly acknowledged huge fines paid by drugmakers and the low esteem consumers have for the companies these days. She said Glaxo will no longer pay bonuses for U.S. sales representatives based on prescriptions.
January 19, 2011 Humans have transformed a defense against noxious fumes -- a receptor at the back of the throat -- into an indicator of gourmet quality in olive oil.
January 18, 2011 Israeli scientists have used stem cells to grow heart cells from patients with a rare heart disease called long QT syndrome. They also tested a variety of drugs on the cells, which they hope will help them develop new treatments for the syndrome.
January 14, 2011 The latest recall, stemming from quality problems at Pennsylvania factory, covers various batches of Tylenol 8 Hour, Tylenol Arthritis Pain and various other medicines made before April 2010.
Vicodin and other popular prescription painkillers also contain acetaminophen, which can damage livers in high doses.
January 13, 2011 The painkiller, sold separately under the brand name Tylenol, can cause serious liver damage in high doses. Many popular prescription medicines for pain contain both acetaminophen and narcotics. People can inadvertently overdose.
January 13, 2011 Two studies bring new evidence to the long-running debate on whether antibiotics work for children's ear infections. But experts say doctors should be sure the child really is suffering from an ear infection before writing a prescription.
<iframe src="http://www.npr.org/player/embed/132869336/132882227" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Drugmakers are helping consumers with copays, but is it such a good deal?
January 7, 2011 Makers of about half the top brand-name prescription drugs now help subsidize consumers' out-of-pocket costs. The assistance can cushion the financial blow for patients but encourage the use of medicines that are more expensive for insurers.
January 6, 2011 In an emotional essay published in a top scientific journal, an esteemed pharmacologist says he's stunned and saddened that underground chemists have used his inventions to make street drugs that kill people.
January 6, 2011 Two weeks of treatment with an antibiotic called rifaximin quelled the symptoms of moderate IBS in 41 percent of the patients who took it. Symptoms improved for 30 percent of people who took a placebo.
<iframe src="http://www.npr.org/player/embed/132702599/132699378" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
January 4, 2011 Even a slick dance video hasn't gotten a couple of million people to sign up for Medicare subsidy. At stake is help worth about $4,000 a year that could defray the costs of prescription drug coverage for people in strapped circumstances.
December 28, 2010 Salvinorin A activates something called the kappa opioid receptors. When turned on, opiod receptors are responsible for the high you get from drugs like heroin and opium. The type affected by the chemical in salvia could help modulate mania.
Sleeping off jet lag is still the way to go.
December 27, 2010 Regulators just gave a second thumbs down to drugmaker Cephalon's application to sell Nuvigil as a remedy for jet lag. The company said it won't try again to win them over.
Study says it might be the ritual of taking placebos that makes them work like pills.
December 23, 2010 A recent study shows that 59 percent of patients who knowingly took a placebo felt better. That's almost twice the improvement reported by people in the control group who took no treatment, researchers at Beth Israel say.
<iframe src="http://www.npr.org/player/embed/132281484/132276866" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
December 20, 2010 Several top medical schools and academic medical centers have not effectively enforced restrictions on pharmaceutical companies' payments to physicians, an investigation by Pro Publica finds. A check of data released by drugmakers reveals problems.
NPR thanks our sponsors
Become an NPR sponsor